MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Substantia nigra"

  • 2026 International Congress

    Reversible encephalitic Parkinsonism due to bilateral substantia nigra lesion showing preserved nigrostriatal dopaminergic activity

    B. Ku, M. Seo, J. Lee, H. Ku (Incheon, Republic of Korea)

    Objective: A case of encephalitic Parkinsonism due to bilateral substantia nigra lesion showing reversible course with preserved nigrostriatal dopaminergic activities. Background: A few cases have…
  • 2026 International Congress

    Single-Cell Transcriptomics and Experimental Models Implicate Functional Hypoxia in Microglial DAM Polarization and α-Synuclein Accumulation, with Involvement of HIF-1α, in Parkinson’s Disease

    H. Wang, Z. Zhu, Z. Yin, K. Zhang (Nanjing, China)

    Objective: To investigate whether microcirculatory impairment-induced hypoxia contributes to the emergence of a late-stage disease-associated microglia (DAM) phenotype and impaired α-synuclein clearance in Parkinson's disease…
  • 2026 International Congress

    The Relationship Between Substantia Nigra Hyperchogenicity and Clinical Features and Disease Progression in Parkinson’s Disease Patients

    WJ. Hu, HH. Luan (Yantai, China)

    Objective: To investigate the relationship between substantia nigra hyperechogenicity (SN+) and clinical features and disease progression in patients with Parkinson's disease (PD) under transcranial sonography…
  • 2026 International Congress

    Lipid Alterations in Central Nervous System and Plasma During Early Stages of Parkinson’s Disease

    P. Thakur, U. Agarwal (Thiruvananthapuram, India)

    Objective: To identify early lipid alterations in a progressive mouse model of Parkinson’s disease (PD) and to determine whether peripheral lipid signatures reflect lipid changes…
  • 2026 International Congress

    Substantia Nigra Free-Water, Metabolic Markers, and Motor Variability in Older Adults with Diabetes

    A. Belnavis, S. Chiu, K. Chen, J. Klein-Seetharaman, E. Ofori (Tempe, USA)

    Objective: To examine whether nigral microstructural integrity measured via substantia nigra free-water MRI (FW-MRI) relates to peripheral metabolic burden and motor variability across the glycemic…
  • 2026 International Congress

    Investigating Substantia Nigra Microstructural Integrity as a Potential Predictive Biomarker for Fall Burden in Parkinson’s Disease

    I. Bedoy, J. Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: Determine whether baseline Diffusion Tensor Imaging (DTI) measures of the substantia nigra (SN) predict fall incidence and burden in Parkinson’s disease (PD). Background: Degeneration of dopaminergic…
  • 2026 International Congress

    Delayed Parkinsonism Following Japanese Encephalitis: A Case Report with Dopamine Transporter Imaging and L-dopa/DCI treatment

    R. Yui, Y. Kobayashi, G. Okumura, M. Katagiri, C. Yuzawa, Y. Shimizu (Ina, Japan)

    Objective: To report a case of Japanese encephalitis (JE) presenting with thalamic–midbrain lesions followed by delayed parkinsonism confirmed by dopamine transporter imaging. Background: JE is…
  • 2026 International Congress

    The Dual Functional Organization of the Substantia Nigra in Parkinson’s Disease

    M. Passaretti, D. Vereb, B. Zufiria-Gerbolés, M. Mijalkov, M. Veronese, J B. Pereira (Stockholm, Sweden)

    Objective: We applied connectopic mapping to the internal functional organisation of the substantia nigra (SN) in independent cohorts. Background: The human SN is a central…
  • 2026 International Congress

    Association of Neurofilament Light Chain with Substantia Nigra Degeneration in Parkinson’s Disease

    WJ. Wu, WQ. Jiang, QY. Zheng, L. Luo, Y. Zhang, XY. Zhang, ZM. Dong, ZY. Yu, T. Wu, XJ. Dai, DL. Zhang (Beijing, China)

    Objective: This study aims to investigate the association between serum neurofilament light chain (NfL), microstructural changes in the substantia nigra, and clinical manifestations in Parkinson’s…
  • 2026 International Congress

    Analysis of Sphingolipid Metabolism Gene Expression in the Parkinson’s Disease Postmortem Brain Dataset

    JL. Li, CH. Lin (New Taipei City, Taiwan)

    Objective: To investigate the landscape of sphingolipid metabolism gene expression in Parkinson’s disease (PD).To investigate the landscape of sphingolipid metabolism gene expression in Parkinson’s disease…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley